Enozertinib
Enozertinib is an investigational new drug that is being developed by Voronoi for the treatment of solid tumors and non-small cell lung cancer.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Enozertinib is an investigational new drug that is being developed by Voronoi for the treatment of solid tumors and non-small cell lung cancer. It is a EGFR receptor antagonist.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1370062589 under CC BY-SA 4.0; modifications have been made.